Anika Therapeutics (ANIK) announced it has appointed John W. Sheets, Jr., Ph.D. as its new Chief Scientific Officer. Dr. Sheets joins Anika from Boston Scientific (BSX), where he was Senior Vice President, Corporate Research.Dr. Sheets replaces Jing-wen Kuo, Ph.D. who is leaving to pursue other opportunities at the end of October. In addition to driving Anika’s research and development efforts, Dr. Sheets is leading the company’s regulatory, clinical affairs and engineering functions. These previously were overseen by COO Frank Luppino, who is leaving Anika at the end of October to pursue other interests. Mr. Luppino’s remaining responsibilities are being smoothly transitioned to existing senior executives, with operations management reporting directly at the CEO level.